Package 65219-811-10

Brand: neostigmine methylsulfate

Generic: neostigmine methylsulfate
NDC Package

Package Facts

Identity

Package NDC 65219-811-10
Digits Only 6521981110
Product NDC 65219-811
Description

10 VIAL, MULTI-DOSE in 1 TRAY (65219-811-10) / 10 mL in 1 VIAL, MULTI-DOSE (65219-811-01)

Marketing

Marketing Status
Marketed Since 2023-01-09
Brand neostigmine methylsulfate
Generic neostigmine methylsulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0831f9a8-b6ff-4b49-91ad-8177f968f543", "openfda": {"upc": ["0365219811015"], "unii": ["98IMH7M386"], "rxcui": ["311936"], "spl_set_id": ["088f96eb-20b8-48f8-ac83-329f75a44ce1"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 TRAY (65219-811-10)  / 10 mL in 1 VIAL, MULTI-DOSE (65219-811-01)", "package_ndc": "65219-811-10", "marketing_start_date": "20230109"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "65219-811_0831f9a8-b6ff-4b49-91ad-8177f968f543", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "65219-811", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "NDA203629", "marketing_category": "NDA", "marketing_start_date": "20150108", "listing_expiration_date": "20261231"}